- Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer
[作者:Manegold, C; Gravenor, D; Woytowitz, D; Mezger, J; Hirsh, V; Albert, G; Al-Adhami, M; Readett, D; Krieg, AM; Leichman, CG,期刊:Journal of clinical oncology, 页码:3979-3986 , 文章类型: Article,,卷期:2008年26-24]
- PurposeThis study assessed the efficacy of the combination of standard taxane plus platinum chemotherapy with the synthetic Toll-like receptor 9-activating oligodeoxynucleotide PF-3512676 in patients with non-small-cell ...
- Palliative thoracic radiotherapy for lung cancer: A systematic review
[作者:Fairchild, A; Harris, K; Barnes, E; Wong, R; Lutz, S; Bezjak, A; Cheung, P; Chow, E,期刊:Journal of clinical oncology, 页码:4001-4011 , 文章类型: Review,,卷期:2008年26-24]
- PurposeThe optimal dose of radiotherapy (RT) to palliate symptomatic advanced lung cancer is unclear. We systematically reviewed randomized controlled trials (RCTs) of palliative thoracic RT.MethodsRCTs comparing two or ...
|